Showing results (411-420 of 2,263) with videos related to
Sort By:
Pageof 227
Plos One|September 10, 2011
Genomic organization, molecular diversification, and evolution of antimicrobial peptide myticin-C genes in the mussel (Mytilus galloprovincialis)Manuel Vera, Paulino Martínez, Laura Poisa-Beiro, et al.BJOG : an International Journal of Obstetrics and Gynaecology|July 14, 2011
Climate and group B streptococci colonisation during pregnancy: present implications and future concernsP Dadvand, X Basagana, F Figueras, et al.Antonie Van Leeuwenhoek|April 1, 1996
Stationary phase development of Trimmatostroma abietisM J Figueras, G S de Hoog, K Takeo, et al.Pediatric Radiology|January 1, 1997
Pulmonary perfusion scintigraphy in the evaluation of the severity of bronchopulmonary dysplasiaC Soler, J Figueras, I Roca, et al.Expert Opinion on Drug Safety|August 18, 2017
Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associationsAdalton Ribeiro, Silvana Lima, Maria-Elisa Zampieri, et al.Child Abuse & Neglect|July 8, 2021
The views of children in residential care on the COVID-19 lockdown: Implications for and their well-being and psychosocial interventionCarme Montserrat, Marta Garcia-Molsosa, Joan Llosada-Gistau, et al.Journal of Hazardous Materials|January 18, 2022
Surgical face masks as a source of emergent pollutants in aquatic systems: Analysis of their degradation product effects in Danio rerio through RNA-SeqMarta Sendra, Patricia Pereiro, María Pilar Yeste, et al.Chronobiology International|October 29, 2021
Seasonal differences in emergency department visits for scooter associated injuriesAndrew Gudeman, Randall T Loder, Jorge Figueras, et al.Fish & Shellfish Immunology|August 18, 2020
Immune-responsive gene 1 (IRG1) and dimethyl itaconate are involved in the mussel immune responseM Sendra, A Saco, M Rey-Campos, et al.Journal of Perinatal Medicine|October 25, 2012
The evolution of risk factors for respiratory syncytial virus-related hospitalisation in infants born at 32-35 weeks' gestational age: time-based analysis using data from the FLIP-2 studyXavier Carbonell, John R Fullarton, Katherine L Gooch, et al.Pageof 227